Skip to main content
. 2020 Apr 25;28(6):669–674. doi: 10.1016/j.jsps.2020.04.007

Fig. 2.

Fig. 2

Various anticancer regimens used in breast cancer patients. AC, anthracycline and cyclophosphamide; FEC, fluorouracil, epirubicin, and cyclophosphamide; TC, taxane and cyclophosphamide.